Lisanti Capital Growth, LLC Crispr Therapeutics Ag Transaction History

Lisanti Capital Growth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$110.72 - $210.04 $615,603 - $1.17 Million	-5,560 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$79.67 - $173.23 $442,965 - $963,158	5,560 New	5,560 $851,000
Q2 2020 Aug 10, 2020	SELL	$38.5 - $76.05 $642,565 - $1.27 Million	-16,690 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $241,654 - $448,652	7,175 Added 75.41%	16,690 $708,000
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $349,010 - $695,831	9,515 New	9,515 $580,000

550

56.3M

2.91M

2.47M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.14B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.